📰 Genetics Home News

Genetics Home News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Genetics Home. Real-time updates on events, politics, business and more.

Swedish Orphan Biovitrum : Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G -October 17, 2023 at 07:21 am EDT

October 17, 2023

Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G 17 October, 2023 13:15 ...

United States Andrew Bomback Tobias Cottman Pediatr Nephrol American Society Of Nephrology European Union

Source: marketscreener.com

Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G

October 17, 2023

/PRNewswire/ -- Sobi® and Apellis Pharmaceuticals, Inc. today announced that positive results from the Phase 2 NOBLE study investigating pegcetacoplan for the...

United States Lydia Abad Franch Tobias Cottman Prnewswire Sobi Andrew Bomback Head Of Communications

Source: prnewswire.com

Hansa Biopharma and partner Sarepta Therapeutics plan to initiate a clinical study with imlifidase as a pre-treatment to Sarepta's SRP-9001 gene therapy in DMD in 2023

November 3, 2022

/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that...

Hansa Biopharma Klaus Sindahl National Institutes Of Health Nasdaq Stockholm Sarepta Therapeutics Biologics License Application

Source: prnewswire.com

Swedish Orphan Biovitrum AB: First patient dosed in the VALIANT phase 3 study of pegcetacoplan for IC-MPGN and C3G, rare kidney diseases with high unmet medical need

June 7, 2022

STOCKHOLM, June 7, 2022 /PRNewswire/ -- Sobi (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the first patient has been dosed in the VALIANT phase 3 study investigating

United States Saudi Arabia United Kingdom Anders Ullman Jeffrey Eisele Pediatr Nephrol

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation